Loading...
Please wait, while we are loading the content...
Exercise-induced attenuation of treatment side-effects in newly diagnosed prostate cancer patients beginning androgen deprivation therapy: a randomised controlled trial.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Ndjavera, W. Orange, Samuel T. Doherty, Alasdair F. O’ Leicht, A. S. Rochester, Mark A. Mills, Robert D. Saxton, J. M. |
| Copyright Year | 2019 |
| Abstract | OBJECTIVES 1) To assess whether exercise training attenuates the adverse effects of treatment in newly diagnosed prostate cancer patients beginning androgen deprivation therapy (ADT), and 2) to examine whether exercise-induced improvements are sustained after the withdrawal of supervised exercise. PATIENTS AND METHODS Fifty prostate cancer patients scheduled for ADT were randomised to an exercise group (n = 24) or a control group (n = 26). The exercise group completed 3-months of supervised aerobic and resistance exercise training (2x/week for 60 min), followed by 3-months of self-directed exercise. Outcomes were assessed at baseline, 3-months, and 6-months. The primary outcome was difference in fat mass at 3-months. Secondary outcomes included fat-free mass, cardiopulmonary exercise testing variables, QRISK2 score, anthropometry, blood-borne biomarkers, fatigue, and quality of life (QoL). RESULTS At 3-months, exercise training prevented adverse changes in peak oxygen uptake (1.9 ml.kg-1 .min-1 , p = 0.038), ventilatory threshold (1.7 ml.kg-1 .min-1 , p = 0.013), oxygen uptake efficiency slope (0.21, p = 0.005) and fatigue (4.5, p = 0.024) compared with controls. After the supervised exercise was withdrawn, the differences in cardiopulmonary fitness and fatigue were not sustained, but the exercise group showed significantly higher QoL (8.5, p = 0.034) and a reduced QRISK2 score (-2.9%, p = 0.041) compared to controls. CONCLUSION A short-term programme of supervised exercise for prostate cancer patients beginning ADT results in sustained improvements in QoL and cardiovascular event risk profile. |
| File Format | PDF HTM / HTML |
| DOI | 10.1111/bju.14922 |
| PubMed reference number | 31605663 |
| Journal | Medline |
| Alternate Webpage(s) | http://nrl.northumbria.ac.uk/40973/2/PROSCARDIO_submitted_v1.pdf |
| Alternate Webpage(s) | https://doi.org/10.1111/bju.14922 |
| Journal | BJU international |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |